Back to all papers

An MRI-pathology foundation model for noninvasive diagnosis and grading of prostate cancer.

Authors

Shao L,Liang C,Yan Y,Zhu H,Jiang X,Bao M,Zang P,Huang X,Zhou H,Nie P,Wang L,Li J,Zhang S,Ren S

Affiliations (14)

  • School of Internet, Anhui University, Hefei, China.
  • CAS Key Laboratory of Molecular Imaging, Institute of Automation, Beijing, China.
  • Department of Urology, The First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital, Nanjing, China.
  • Department of Urology, Peking University Third Hospital, Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital and Institute, Beijing, China.
  • Chongqing Engineering Research Center of Medical Electronics and Information Technology, Chongqing University of Post and Telecommunications, Chongqing, China.
  • Department of Pathology, The First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital, Nanjing, China.
  • Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China.
  • Department of Automation, Tsinghua University, Beijing, China.
  • Department of Radiology, The Affiliated Hospital of Qingdao University, Qingdao, China. [email protected].
  • Department of Radiology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China. [email protected].
  • Department of Urology, The First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital, Nanjing, China. [email protected].
  • Department of Urology, Peking University Third Hospital, Beijing, China. [email protected].
  • Department of Urology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China. [email protected].

Abstract

Prostate cancer is a leading health concern for men, yet current clinical assessments of tumor aggressiveness rely on invasive procedures that often lead to inconsistencies. There remains a critical need for accurate, noninvasive diagnosis and grading methods. Here we developed a foundation model trained on multiparametric magnetic resonance imaging (MRI) and paired pathology data for noninvasive diagnosis and grading of prostate cancer. Our model, MRI-based Predicted Transformer for Prostate Cancer (MRI-PTPCa), was trained under contrastive learning on nearly 1.3 million image-pathology pairs from over 5,500 patients in discovery, modeling, external and prospective cohorts. During real-world testing, prediction of MRI-PTPCa demonstrated consistency with pathology and superior performance (area under the curve above 0.978; grading accuracy 89.1%) compared with clinical measures and other prediction models. This work introduces a scalable, noninvasive approach to prostate cancer diagnosis and grading, offering a robust tool to support clinical decision-making while reducing reliance on biopsies.

Topics

Journal Article

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.